Company intelligence / Profile preview
Genelux Corporation
Westlake Village, California, USAgenelux.com ↗
- Ownership
- Public · GNLX
- Development stage
- Phase 3
01
Overview
Genelux’s lead candidate Olvi‐Vec has shown positive topline results in the Phase II VIRO‐15 trial for heavily pretreated patients with platinum-resistant or refractory ovarian cancer. The data demonstrated independent anti-tumor activity and reversal of platinum resistance in the tumor microenvironment. Over more than a decade of clinical studies (>150 patients), Olvi‐Vec has been generally well tolerated with evidence of clinical benefit[5].
- Therapeutic areas
- Oncology
- Modalities
- Oncolytic viruses (specifically, modified vaccinia virus)Immunotherapy[1][5]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Newsoara BioPharma Co. Ltd. – licensing agreement for research, development, commercialization or exploitation of Olvi‑Vec in China and certain territories[3].
04
Financials
- Market cap
- $111.2M
- Total revenue
- $0
- Enterprise value
- $95M
Beyond the preview
Go deeper on Genelux Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genelux Corporation.